Related Experiment Videos
Buprenorphine detection in biological samples.
Nadia De Giovanni1, Nadia Fucci, Salvatore Scarlata
1Istituto di Medicina Legale e delle Assicurazioni, Università Cattolica del Sacro Cuore, Rome, Italy. fortox@rm.unicatt.it
Clinical Chemistry and Laboratory Medicine
|November 29, 2005
Summary
A Buprenorphine One-step ELISA test, designed for serum, was evaluated for qualitative detection in urine, saliva, and hair. This immunoassay offers a rapid screening tool for buprenorphine in diverse biological samples.
Area of Science:
- Clinical Chemistry
- Toxicology
- Forensic Science
Background:
- Buprenorphine is a potent narcotic analgesic for moderate-to-severe pain.
- It is increasingly used in Italy for treating heroin abuse disorder.
- Accurate screening methods are crucial for therapeutic monitoring and forensic analysis.
Purpose of the Study:
- To evaluate the Buprenorphine One-step ELISA test for qualitative buprenorphine determination.
- To assess the test's applicability beyond serum, in matrices like urine, saliva, and hair.
- To determine the suitability of this immunoassay as a rapid screening tool.
Main Methods:
- Qualitative evaluation of the Buprenorphine One-step ELISA test.
- Testing of serum specimens as per manufacturer's design.
- Analysis of alternative biological matrices: urine, saliva, and hair.
Main Results:
- The Buprenorphine One-step ELISA test demonstrated potential for qualitative buprenorphine detection.
- The study assessed the test's performance across multiple biological matrices.
- Results indicate the immunoassay's utility as a preliminary screening method.
Conclusions:
- The Buprenorphine One-step ELISA is a viable rapid screening tool for buprenorphine.
- Its application can be extended to urine, saliva, and hair analysis.
- This immunoassay supports the monitoring of buprenorphine treatment and abuse.